Podcasts about teleneurology

Ziv Yekutieli CEO of Mon4t a company that turns any standard smartphone into a sophisticated, personalized neurological medical testing device for remote and in-person testing the data of which can be used monitoring of neurological and psychiatric patients. He started his career as an electrical engineer, having experienced one of his teachers suffer from ALS, he began to study neurology alongside engineering eventually going on to study a PhD in Brain Science whilst in his engineering career eventually going to cofound Mon4t. In this episode, we discuss his journey from studying medicine and engineering to connecting neurology and technology, the prevalence of neurological conditions affecting up to one in eight people, how the number of neurologists per capita is falling and his advice for aspiring entrepreneurs to know the box before thinking outside of it. Timestamps: [00:00:01] How Telehealth accelerates teleneurology treatment [00:06:36] Telehealth advancing neurology and its complexity [00:14:02] Neurology, engineering, technology: lifelong journey [00:22:08] Know the box, identify beachhead, nurturing customers [00:28:31] Exploring brain and starting a business Get in touch with Ziv Yekutieli - https://www.linkedin.com/in/ziv-yekutieli/ https://mon4t.com/ Get in touch with Karandeep Badwal - https://www.linkedin.com/in/karandeepbadwal/ Follow Karandeep on YouTube - https://www.youtube.com/@KarandeepBadwal Subscribe to the Podcast --- Support this podcast: https://podcasters.spotify.com/pod/show/themedtechpodcast/support

In this thought-provoking episode, we are joined by Andy Kim, M.D., a board-certified, fellowship-trained pediatric neurologist, and Barbara Carr, M.D., a neonatologist and specialty medical officer at Pediatrix, to delve deep into Pediatrix's teleneurology program that was initiated to address the need for highly specialized pediatric care for hospitalized patients, offering a solution for complex cases that require expert consultation.This episode is sponsored by Pediatrix.

In this week's podcast, Neurology Today's editor-in-chief discusses a comparison of spinal cord stimulation with medical management for chronic pain, earlier brain aging in Black people, and the pros/cons of working for teleneurology companies.

Equitable tele-neurologic care starts with first identifying disparities, then identifying how to overcome them – learn about both with Dr. Lee Schwamm on the latest ANA Investigates. Series 3, Episode 11. Featuring: Guest: Dr. Lee Schwamm, C Miller Fisher Endowed Chair in Vascular Neurology and the Director of the Center for TeleHealth at Massachusetts General Hospital, Professor of Neurology at Harvard Medical School and Vice President for Digital Patient Experience at the Mass General Brigham Health System. Interviewer/Producer: Amanda Jagolino-Cole, Director of the UT Teleneurology Division at McGovern Medical School at the University of Texas Health Science Center in Houston. Disclosures: None

In this week's podcast, Neurology Today's editor-in-chief discusses the challenges and opportunities of teleneurology in rural areas, the effect of childhood trauma on neurologic disorders, and genetics advances in neurology.

Dr. Matthew Hart discusses his abstract, "Hospital Teleneurology Role Leads to Significant Wait Time Reduction for Follow Up Appointments and Increased Access to Subspecialists". Show references: https://index.mirasmart.com/aan2022/PDFfiles/AAN2022-002138.html    

Dr. Katrina Ignacio discusses the emerging subspecialty of teleneurology and telestroke.

Telemedicine is not a new invention but played a key role in the months of isolation during the pandemic. For many patients, it was the only way to continue their treatment and stay in touch with their doctors. The growth of telemedicine has been evident, but what will be left once people return to normal life? We discuss this with Professor Paul Boon, President Elect of the European Academy of Neurology (EAN).For more information about the Brain Innovation Days and Brain Talks series, please visit braininnovationdays.eu

SOC Telemed (SOC) is one of the largest national providers of telemedicine technology and solutions to hospitals, health systems, post-acute providers, physician networks, and value-based care organizations. Built on proven and scalable infrastructure as an enterprise-wide solution, SOC's technology platform, Telemed IQ, rapidly deploys and seamlessly optimizes telemedicine programs across the continuum of care. SOC provides a supportive and dedicated partner presence, virtually delivering patient care through teleNeurology, telePsychiatry and teleICU, enabling healthcare organizations to build sustainable telemedicine programs in any clinical specialty. SOC enables organizations to enrich their care models and touch more lives by supplying healthcare teams with industry-leading solutions that drive improved clinical care, patient outcomes, and organizational health. The company was the first provider of acute clinical telemedicine services to earn The Joint Commission's Gold Seal of Approval and has maintained that accreditation every year since inception.

Dr. Jason Crowell talks with Dr. Neil Busis and Dr. Brad Klein about teleneurology, tips for billing, and exams during the COVID-19 pandemic. Full interview: https://neurology.libsyn.com/website/special-report-neil-busis-brad-klein-make-teleneurology-easy-fun-tips-for-billing-and-physical-exams Read the special editorial by Drs. Busis and Klein: https://n.neurology.org/content/early/2020/04/24/WNL.0000000000009494

Justin McArthur, MBBS, MPH, FANA, and Steven Zeiler, MD, PhD, discuss the benefits and challenges of teleneurology, especially as the COVID-19 pandemic wears on, and how you can start implementing teleneurology into your own practice. For more podcasts like this, visit www.consultant360.com/neurology.

Dr. Melissa Ko shares tips and updates about telemedicine for neurologists caring for patients in light of COVID-19

Dr. Jason Crowell talks with Dr. Neil Busis and Dr. Brad Klein about teleneurology, tips for billing, and exams during the COVID-19 pandemic. Read the special editorial by Drs. Busis and Klein: https://n.neurology.org/content/early/2020/04/24/WNL.0000000000009494. For a clearing house of neurology related information on the coronavirus go to AAN.com/COVID19 to stay up-to-date.

Dr. Teshamae Monteith talks with Dr. Melissa Ko about telemedicine for neurologists caring for patients in light of COVID-19. For a clearing house of neurology related information on the coronavirus go to AAN.com/COVID19 to stay up-to-date.

Marisa McGinley, DO shares the first published data on the use of telemedicine in a large-scale neurology practice, and how others can adopt this technology for their own practice.

We're at the American Academy of Neurology Annual Meeting in Philadelphia, and we're talking about teleneurology, stem cells, a new algorithm, and a new research network with ambitious goals. Today, it's a real peek into the future! We have a lot to talk about! Are you ready for RealTalk MS??!

In this episode Birdman discusses Telemedicine with Kristi Iannucci, the Telehealth/Lean Improvement Specialist at Summit Healthcare Regional Medical Center. Video @ https://youtu.be/D0INA0T-RH8 Visit https://summithealthcare.net/     Summit Healthcare Provides Teleneurology Care In an effort to offer neurological services to the area Summit Healthcare continues to provide state-of-the-art telemedicine coverage to patients in the White Mountains. Current telemedicine programs offered through the Emergency Room at Summit Healthcare are Telestroke, Teleconcussion, and Teleneurology. Summit Healthcare is able to provide patients suffering from a stroke or having neurological symptoms a direct consultation with a board-certified neurologist 24/7. Through video conference technology we are able to connect the neurologist to the patient at Summit without having to leave the mountain for a consultation and provide our patients with quality care at Summit Healthcare Regional Medical Center.   More and more patients in remote locations are being served by telemedicine, which is the use of medical information exchanged from one site to another via electronic communications to improve a patient’s clinical health status. For example, Summit Healthcare Regional Medical Center offers telestroke services that allow a patient in our Emergency Department to be seen by a board-certified neurologist who can make a diagnosis and then deliver services through instructions to our emergency staff. Summit Healthcare also works with telemedicine partners to provide neurology, concussion, nursery, radiology, and psychiatry services. Planning is underway for telemedicine burn services. We are also developing a pilot program to integrate primary care and behavioral health as part of a grant-funded partnership.

1) HIV associated motor neuron disease: HERV-K activation and response to anti-retroviral therapy 2) e-Pearl topic: Ataxia with vitamin E deficiency3) Topic of the month: Neurology Today story on functional outcomes of pre-hospital thrombolysis in a mobile stroke treatment unit compared with conventional careThis podcast for the Neurology Journal begins and closes with Dr. Robert Gross, Editor-in-Chief, briefly discussing highlighted articles from the print issue of Neurology. In the second segment Dr. Ted Burns interviews Dr. Avindra Nath about his paper on human endogenous retrovirus-K in amyotrophic lateral sclerosis with HIV infection and response to treatment with anti-retroviral drugs. Dr. Sarah Wesley is reading our e-Pearl of the week about ataxia with vitamin E deficiency. In the next part of the podcast Dr. Andy Southerland interviews Prof. Heinrich Audebert about a Neurology Today story on the topic of functional outcomes of pre-hospital thrombolysis in a mobile stroke treatment unit compared with conventional care.DISCLOSURES: Dr. Ted Burns serves as Podcast Editor for Neurology®; and has received research support for consulting activities with UCB, CSL Behring, Walgreens and Alexion Pharmaceuticals, Inc.Dr. Nath serves as Associate Editor for Journal of Neurovirology; has patents for Tat as an immunogen, Diosgenin for Treatment of Neurodegenerative Diseases; Role of Kv Channels in Neuroregeneration and Protection; Role of Lominoid compounds as neuroprotective agents; Tat ELISA; and receives research support from the NIH.Dr. Wesley serves on the editorial team for the Neurology® Resident and Fellow Section. Dr. Southerland serves as Podcast Deputy Editor for Neurology; receives research support from the American Heart Association-American Stroke Association National Clinical Research Program, American Academy of Neurology, American Board of Psychiatry and Neurology, Health Resources Services Administration and the NIH; has a provisional patent application titled: “Method, system and computer readable medium for improving treatment times for rapid evaluation of acute stroke via mobile telemedicine;” and gave legal expert review. Prof. Audebert serves as Associate Editor for Frontiers of Teleneurology; is a consultant for Lundbeck Inc., Roche, Bayer Schering Pharma, Pfizer Inc; received speaker honoraria from Takeda Pharmaceutical Company Limited, Boehringer Ingelheim, Lundbeck Inc., Bayer Schering Pharma, UCB, Sanofi-aventis, Pfizer Inc, Bristol-Myers Squibb and EverNeuropharma; participated in an expert meeting launched by Lundbeck Inc. in order to estimate the target population for Desmoteplase; receives research support from the Technology Foundation Berlin and the Berlin Investment Bank with co-financing by the European Union, and Center for Stroke Research Berlin, funded by the German Federal Ministry of Education and Research.

1) Predictors for atrial fibrillation detection after cryptogenic stroke: Results from CRYSTAL AF2) e-Pearl topic: Treatment of pediatric onset neuromyelitis optica3) Topic of the month: Endovascular Stroke Therapy This podcast for the Neurology Journal begins and closes with Dr. Robert Gross, Editor-in-Chief, briefly discussing highlighted articles from the print issue of Neurology. In the second segment Dr. Bryan Eckerle interviews Dr. Vincent Thijs about his paper on predictors for atrial fibrillation detection after cryptogenic stroke. Dr. Adam Numis is reading our e-Pearl of the week about treatment of pediatric onset neuromyelitis optica. In the next part of the podcast Dr. Prachi Mehndiratta interviews Dr. Lee H. Schwamm about the topic of implications for stroke systems of care in endovascular stroke therapy. DISCLOSURES: Dr. Thijs serves as an Associate Editor for Acta Neurologica Belgica; serves as an editorial board member of Stroke and European Journal of Emergency Medicine; serves on the scientific advisory board for Sygnis Ax200 steering committee, Boehringer Ingelheim Belgium advisory board, Boehringer Ingelheim international advisory board, Medtronic steering committee of the REACT-AF trial; is a consultant for Boehringer Ingelheim, Pfizer Inc, Bayer Schering Pharma, AstraZeneca. Medtronic, Inc.; serves on the speakers bureau of Pfizer Inc, Boehringer Ingelheim and Medtronic, Inc.; received funding for travel or speaker honoraria from Medtronic, Inc.; Boehringer Ingelheim, Pfizer Inc, and Bayer Schering Pharma; receives research support from SYGNIS AG, Medtronic, Inc., Pfizer Inc, AstraZeneca, Boehringer Ingelheim and VIB Flanders Research Fund (FWO).Dr. Numis serves on the editorial team for the Neurology Resident and Fellow Section.Dr. Schwamm serves on the scientific advisory board for CoAxia, Lundbeck Inc. DIAS 4 steering Committee, LifeImage and Medtronic, Inc.; serves as an editorial board member for Neurocritical Care, Stroke and Frontiers in TeleNeurology; receives royalties from the publication of the book Acute Ischemic Stroke: Imaging and Intervention, 2nd Edition; is a consultant for Lundbeck Inc. DIAS 4 steering Committee, LifeImage, Medtronic, Inc., and Massachusetts Department of Public Health; has a patent for Imaging system for obtaining quantitative perfusion indices. US Patent 6,542,769. 2003 Apr 1, The General Hospital Corporation assignee, Inventors: Schwamm LH and Sorensen AG; is the principal investigator of an investigator-initiated study of extended-window intravenous thrombolysis funded by the National Institutes of Neurological Disorders and Stroke (clinicaltrials.gov/show/NCT01282242) for which Genentech provides alteplase free of charge to Massachusetts General Hospital as well as supplemental per-patient payments to participating sites; is the chair of the AHA/ASA GWTG stroke clinical work group.

1) Pre-hospital thrombolysis and 2) Topic of the month: Headaches. This podcast for the Neurology Journal begins and closes with Dr. Robert Gross, Editor-in-Chief, briefly discussing highlighted articles from the print issue of Neurology. In the second segment Dr. Andy Southerland interviews Dr. Joachim Weber about his paper on pre-hosptial thrombolysis. Dr. Jen Fugate is reading our e-Pearl of the week about Ondine's curse. In the next part of the podcast Dr. Jen Bickel interviews Dr. Todd Rozen about the topic of cluster headaches. The participants had nothing to disclose except Drs. Audebert and Fugate.Dr. Audebert serves as Associate Editor for Frontiers of Teleneurology; is a consultant for Lundbeck Inc.; receives speaker honoraria from Takeda Pharmaceutical Company Limited, Boehringer Ingelheim, Lundbeck Inc., Bayer Vital, UCB, Sanofi-Syntelabo Inc and Pfizer Inc; receives research support from Center for Stroke Research Berlin funded by the German Federal Ministry of Education and Research and funding of the STEMO project by the Technology Foundation Berlin with co-financing by the European Union; serves on the speakers' bureau of German TeleStroke Networks within the Competence Network Stroke and gave expert testimony in a trial launched by Lundbeck Inc. Dr. Fugate serves on the editorial team for the Neurology® Resident and Fellow Section.